HPCB-3003N

Hazard statements (CLP)

H302, H312, H315, H320, H332, H350, H351, H371

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

2.2 Label elements

2 HEALTH 0 0 FLAMMABILITY 2 0

Signal word

DANGER

Hazard statements

H302 - Harmful if swallowed. (Acute toxicity, oral, category 4) H312 - Harmful if absorbed through skin. (Acute toxicity, dermal, category 4) H315 - Irritating to skin. (Skin corrosion/irritation, category 2) H320 - Irritating to eyes. (Eye damage/irritation, category 2B) H332 - Harmful if inhaled. (Acute toxicity, inhalation, category 4) H350 - This product is or contains a component that is classified (ACGIH, IARC, NTP, OSHA) as a possible cancer hazard. (Carcinogenicity, category 1B) H351 - The consistent finding in animal studies with PCB’s is that they produce liver injury and are suspected of causing cancer following prolonged and repeated exposure by any route, if the exposure is of sufficient degree and duration. Liver injury is produced first, and by exposures that are less than those reported to cause cancer in rodents. Therefore, exposure by all routes should be kept sufficiently low to prevent liver injury. (Carcinogenicity, category 1B) H371 - May cause liver damage. (Specific target organ toxicity, single exposure, category 2) Precautionary Codes: P202 - This product should only by used by persons trained in the safe handling of hazardous chemicals. P233 - Store in a tightly closed container. (P404) P262 - Do not get in eyes, on skin or clothing. P264 - Wash thoroughly after handling. Do not take internally. Eye wash and safety equipment should be readily available. P280 - Protective gloves must be worn to prevent skin contact. P284 - Respiratory Protection: If workplace exposure limit(s) of product or any component is exceeded (see TLV/PEL), or a risk assessment shows air-purifying respirators are appropriate, use of a NIOSH/MSHA approved air supplied respirator is advised. Use a full-face respirator with multi-purpose combination (US) or type ABEK (EN14387) respirator cartridges in absence of proper environmental control. Always use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Engineering and/or administrative controls should be implemented to reduce exposure. P338 - Eye contact: Immediately flush with plenty of water. After initial flushing, remove any contact lenses and continue flushing for at least 15 minutes. Assure adequate flushing by separating the eyelids with fingers. P340 - Inhalation: Remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical attention. P360 - Skin contact: Immediately wash skin with soap and plenty of water. Remove contaminated clothing. Get medical attention if symptoms occur. Wash clothing before reuse.

2.3 Other hazards

2.2.1 - Symptom of Exposure Health/Environment Prolonged or repeated contact can result in defatting and drying of the skin which may result in skin irritation or dematitis (rash). May cause liver damage. (Specific target organ toxicity, single exposure, category 2) Overexposure may cause reproductive disorders based on tests with laboratory animals. The consistent finding in animal studies with PCB’s is that they produce liver injury and are suspected of causing cancer following prolonged and repeated exposure by any route, if the exposure is of sufficient degree and duration. Liver injury is produced first, and by exposures that are less than those reported to cause cancer in rodents. Therefore, exposure by all routes should be kept sufficiently low to prevent liver injury. (Carcinogenicity, category 1B)

Potential health effects

Irritating to eyes. (Eye damage/irritation, category 2B) Irritating to skin. (Skin corrosion/irritation, category 2) Harmful if absorbed through skin. (Acute toxicity, dermal, category 4) Irritating to mucous membrane and upper respiratory system. Harmful if inhaled. (Acute toxicity, inhalation, category 4) Harmful if swallowed. (Acute toxicity, oral, category 4) 2.2.3 - Routes of Entry Inhalation, ingestion or skin contact. 2.2.4 - Carcinogenicity